Refractory Progressive Multiple Sclerosis clinical trials

Explore recruiting refractory progressive multiple sclerosis clinical trials.

Recruiting refractory progressive multiple sclerosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Refractory Progressive Multiple Sclerosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A SINGLE-ARM, OPEN-LABEL, PHASE I STUDY TO DETERMINE THE SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY OF OBE-CEL IN PARTICIPANTS WITH REFRACTORY PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Refractory Progressive Multiple Sclerosis trials by city

Refractory Progressive Multiple Sclerosis in Toronto Refractory Progressive Multiple Sclerosis in Vancouver Refractory Progressive Multiple Sclerosis in Montreal Refractory Progressive Multiple Sclerosis in Calgary Refractory Progressive Multiple Sclerosis in Edmonton Refractory Progressive Multiple Sclerosis in Ottawa Refractory Progressive Multiple Sclerosis in Winnipeg Refractory Progressive Multiple Sclerosis in Quebec City Refractory Progressive Multiple Sclerosis in Hamilton Refractory Progressive Multiple Sclerosis in Kitchener Refractory Progressive Multiple Sclerosis in London Refractory Progressive Multiple Sclerosis in Halifax Refractory Progressive Multiple Sclerosis in New York Refractory Progressive Multiple Sclerosis in Los Angeles Refractory Progressive Multiple Sclerosis in Chicago Refractory Progressive Multiple Sclerosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease